Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Rheumatoid Arthritis (RA) Drugs Market 2017-2027

Reportlinker
Posted on: 28 Nov 17
Rheumatoid Arthritis (RA) Drugs Market 2017-2027

PR Newswire

NEW YORK, Nov. 28, 2017

NEW YORK, Nov. 28, 2017 /PRNewswire/ -- Trends, Progress and Revenue Forecasting: Evaluation of Classes (Biologic DMARDs, Synthetic DMARDs) and Products Including Humira, Enbrel, Remicade, Rituxan, Actemra and Biosimilars; Assessment of Leading Companies Including AbbVie, Roche, J&J, Amgen, Pfizer and Merck & Co.; Prediction of Leading National Markets; and Investigation of Late-Stage R&D Including IL-6, JAK, BTK and GM-CSF Inhibitors.



Read the full report: https://www.reportlinker.com/p05222501



Report Details
• Do you need definitive Rheumatoid Arthritis market data?
• Succinct Rheumatoid Arthritis market analysis?
• Technological insight?
• Clear competitor analysis?
• Actionable business recommendations?

The introduction of new biologic drugs in Rheumatoid Arthritis, has led Visiongain to publish this timely report. The Rheumatoid Arthritis Drugs market is expected to flourish in the next few years because of rise to prominence of biosimilars that provides a way of reducing the cost of treatment for patients. In addition, the arrival of new JAK inhibitors and BTK inhibitors could provide patients with oral treatments rather than taking their medications intravenously. The expected increases in efficacy are expected to feed through in the latter part of the decade driving growth to new heights. If you want to be part of this growing industry, then read on to discover how you can maximise your investment potential.

Report highlights
• 135 quantitative tables, charts, and graphs across 183 pages
• Analysis of key players in Rheumatoid Arthritis Market
• AbbVie Pharmaceuticals
• Roche Pharmaceuticals
• Johnson & Johnson
• Amgen
• Pfizer
• Merck and Co.
• BMS
• UCB
• Global Rheumatoid Arthritis market outlook and analysis from 2017-2027
• Global Rheumatoid Arthritis Drugs forecasts and analysis from 2017-2027
• Major Biologics drugs forecast 2017-2027
• Major non-biologics drugs forecast 2017-2027
• Leading drugs forecast 2017-2027
• Regional Rheumatoid Arthritis market forecasts from 2017-2027
• US forecast 2017-2027,
• Japan forecast 2017-2027
• India forecast 2017-2027
• Germany forecast 2017-2027
• UK forecast 2017-2027
• France forecast 2017-2027
• Italy forecast 2017-2027
• Spain forecast 2017-2027
• Brazil forecast 2017-2027
• Russia forecast 2017-2027
• China forecast 2017-2027

Key questions answered
• What does the future hold for the Pharmaceutical industry with regards to RA?
• Where should you target your business strategy?
• Which applications should you focus upon?
• Which disruptive technologies should you invest in?
• Which companies should you form strategic alliances with?
• Which company is likely to success and why?
• What business models should you adopt?
• What industry trends should you be aware of?

Target audience
• Leading Pharmaceutical companies
• Suppliers
• Contractors
• Technologists
• R&D staff
• Consultants
• Analysts
• CEO's
• CIO's
• COO's
• Business development managers
• Investors
• Governments
• Agencies
• Banks

Read the full report: https://www.reportlinker.com/p05222501

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/rheumatoid-arthritis-ra-drugs-market-2017-2027-300562948.html

SOURCE Reportlinker

PR Newswire
www.prnewswire.com

Last updated on: 28/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.